Skip to main content
SpringerLink
Log in

Clinical Aspect: Esophageal Cancer

  • Chapter
  • First Online:
Lymph Node Metastasis in Gastrointestinal Cancer

  • 783 Accesses

Abstract

Lymph node micrometastasis (LNM), including isolated tumor cells (ITC), has recently been the focus of study for the development of a biological method to detect lymph node metastasis in various malignant neoplasms. The applicability of immunohistochemistry (IHC) and reverse transcription-polymerase chain reactions (RT-PCR) to the detection of LNM in esophageal cancer has already been reported. However, the clinical significance of LNM currently remains unclear in patients with esophageal cancer. The presence of LNM is clinically important in patients without nodal metastasis in a routine histological examination (pN0) because patients with pN0, but also with LNM already exhibit metastatic potential. Accurate evaluations need to be performed using the same antibody or primer as well as the same technique in a large number of patients. A rapid diagnosis of LNM using IHC and RT-PCR during surgery will be clinically useful. Minimally invasive treatments such as endoscopic submucosal dissection and laparoscopic surgery with individualized lymphadenectomy are now being increasingly performed in consideration of postsurgical quality of life (QOL). However, it is important to maintain the balance between QOL and curability when selecting surgical treatments for patients with esophageal cancer. We reviewed the clinical significance of LNM as an important strategic target in patients with esophageal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Robey-Cafferty SS, el-Naggar AK, Sahin AA, Bruner JM, Ro JY, Cleary KR. Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy. Am J Clin Pathol. 1991;95(6):844–9.

    CAS  PubMed  Google Scholar 

  2. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg. 1994;81(3):410–3.

    CAS  PubMed  Google Scholar 

  3. Dimick JB, Pronovost PJ, Cowan JA Jr, Lipsett PA, Stanley JC, Upchurch GR Jr. Variation in postoperative complication rates after high-risk surgery in the United States. Surgery. 2003;134(4):534–40. discussion 40-1

    PubMed  Google Scholar 

  4. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–37.

    PubMed  Google Scholar 

  5. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280(20):1747–51.

    CAS  PubMed  Google Scholar 

  6. Lambert R. Treatment of esophagogastric tumors. Endoscopy. 2003;35(2):118–26.

    CAS  PubMed  Google Scholar 

  7. Tilanus HW, Hop WC, Langenhorst BL, van Lanschot JJ. Esophagectomy with or without thoracotomy. Is there any difference? J Thorac Cardiovasc Surg. 1993;105(5):898–903.

    CAS  PubMed  Google Scholar 

  8. Uenosono Y, Arigami T, Yanagita S, Kozono T, Arima H, Hirata M, et al. Sentinel node navigation surgery is acceptable for clinical T1 and N0 esophageal cancer. Ann Surg Oncol. 2011;18(7):2003–9.

    PubMed  Google Scholar 

  9. Hagihara T, Uenosono Y, Arigami T, Kozono T, Arima H, Yanagita S, et al. Assessment of sentinel node concept in esophageal cancer based on lymph node micrometastasis. Ann Surg Oncol. 2013;20(9):3031–7.

    PubMed  Google Scholar 

  10. Takeuchi H, Kawakubo H, Takeda F, Omori T, Kitagawa Y. Sentinel node navigation surgery in early-stage esophageal cancer. Ann Thorac Cardiovasc Surg. 2012;18(4):306–13.

    PubMed  Google Scholar 

  11. Natsugoe S, Aikou T, Shimada M, Yoshinaka H, Takao S, Shimazu H, et al. Occult lymph node metastasis in gastric cancer with submucosal invasion. Surg Today. 1994;24(10):870–5.

    CAS  PubMed  Google Scholar 

  12. Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997;337(17):1188–94.

    CAS  PubMed  Google Scholar 

  13. Natsugoe S, Mueller J, Stein HJ, Feith M, Hofler H, Siewert JR. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer. 1998;83(5):858–66.

    CAS  PubMed  Google Scholar 

  14. Matsumoto M, Natsugoe S, Nakashima S, Sakamoto F, Okumura H, Sakita H, et al. Clinical significance of lymph node micrometastasis of pN0 esophageal squamous cell carcinoma. Cancer Lett. 2000;153(1–2):189–97.

    CAS  PubMed  Google Scholar 

  15. Arigami T, Natsugoe S, Uenosono Y, Mataki Y, Ehi K, Higashi H, et al. Evaluation of sentinel node concept in gastric cancer based on lymph node micrometastasis determined by reverse transcription-polymerase chain reaction. Ann Surg. 2006;243(3):341–7.

    PubMed  PubMed Central  Google Scholar 

  16. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995;55(15):3417–20.

    CAS  PubMed  Google Scholar 

  17. Raj GV, Moreno JG, Gomella LG. Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer. 1998;82(8):1419–42.

    CAS  PubMed  Google Scholar 

  18. Sobin L, Wittekind C. TNM classification of malignant tumours. 6th ed. New York: Wiley; 2002. (International Union Against Cancer)

    Google Scholar 

  19. Sobin L, Wittenkind C. TNM classification of malignant tumors. 6th ed. New York: John Wiley-Liss; 2002.

    Google Scholar 

  20. Kinjo T, Shimoji H, Nagahama M, Karimata H, Yoshimi N, Nishimaki T. Prognostic significance of simultaneous presence of histological and immunohistochemical metastasis to lymph nodes in patients with esophageal cancer. Ann Thorac Cardiovasc Surg. 2014;20(6):951–60.

    PubMed  Google Scholar 

  21. Prenzel KL, Holscher AH, Drebber U, Agavonova M, Gutschow CA, Bollschweiler E. Prognostic impact of nodal micrometastasis in early esophageal cancer. Eur J Surg Oncol. 2012;38(4):314–8.

    CAS  PubMed  Google Scholar 

  22. Koenig AM, Prenzel KL, Bogoevski D, Yekebas EF, Bubenheim M, Faithova L, et al. Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma. Ann Surg Oncol. 2009;16(2):454–62.

    PubMed  Google Scholar 

  23. Shiozaki H, Fujiwara Y, Hirai T. Clinical significance of immunohistochemically detected lymph node micrometastasis in patients with histologically node-negative esophagealcarcinoma: a multi-institutional study. Esophagus. 2007;4:35–9.

    Google Scholar 

  24. Tanabe T, Nishimaki T, Watanabe H, Ajioka Y, Akazawa K, Komukai S, et al. Immunohistochemically detected micrometastasis in lymph nodes from superficial esophageal squamous cell carcinoma. J Surg Oncol. 2003;82(3):153–9.

    PubMed  Google Scholar 

  25. Komukai S, Nishimaki T, Suzuki T, Kanda T, Kuwabara S, Hatakeyama K. Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma. Br J Surg. 2002;89(2):213–9.

    CAS  PubMed  Google Scholar 

  26. Doki Y, Ishikawa O, Mano M, Hiratsuka M, Sasaki Y, Kameyama M, et al. Cytokeratin deposits in lymph nodes show distinct clinical significance from lymph node micrometastasis in human esophageal cancers. J Surg Res. 2002;107(1):75–81.

    PubMed  Google Scholar 

  27. Sato F, Shimada Y, Li Z, Watanabe G, Maeda M, Imamura M. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg. 2001;88(3):426–32.

    CAS  PubMed  Google Scholar 

  28. Glickman JN, Torres C, Wang HH, Turner JR, Shahsafaei A, Richards WG, et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer. 1999;85(4):769–78.

    CAS  PubMed  Google Scholar 

  29. Matsumoto M, Natsugoe S, Ishigami S, Uenosono Y, Takao S, Aikou T. Rapid immunohistochemical detection of lymph node micrometastasis during operation for upper gastrointestinal carcinoma. Br J Surg. 2003;90(5):563–6.

    CAS  PubMed  Google Scholar 

  30. Noura S, Yamamoto H, Miyake Y, Kim B, Takayama O, Seshimo I, et al. Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. Clin Cancer Res. 2002;8(3):759–67.

    PubMed  Google Scholar 

  31. Li SH, Wang Z, Liu XY, Liu FY, Sun ZY, Xue H. Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer. Surg Today. 2007;37(12):1047–52.

    CAS  PubMed  Google Scholar 

  32. Godfrey TE, Raja S, Finkelstein SD, Gooding WE, Kelly LA, Luketich JD. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients. Clin Cancer Res. 2001;7(12):4041–8.

    CAS  PubMed  Google Scholar 

  33. Xi L, Luketich JD, Raja S, Gooding WE, Litle VR, Coello MC, et al. Molecular staging of lymph nodes from patients with esophageal adenocarcinoma. Clin Cancer Res. 2005;11(3):1099–109.

    CAS  PubMed  Google Scholar 

  34. Sun ZG, Wang Z, Liu XY, Liu FY. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy. World J Surg. 2011;35(1):70–7.

    PubMed  Google Scholar 

  35. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol. 1994;12(4):725–9.

    CAS  PubMed  Google Scholar 

  36. Song ZB, Gao SS, Yi XN, Li YJ, Wang QM, Zhuang ZH, et al. Expression of MUC1 in esophageal squamous-cell carcinoma and its relationship with prognosis of patients from Linzhou city, a high incidence area of northern China. World J Gastroenterol. 2003;9(3):404–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Wang Z, Yin H. Diagnosis of occult metastasis to mediastinal lymph nodes in patients with NSCLC: detection of MUC1 mRNA by reverse transcriptase-polymerase chain reaction (RT-PCR). Zhongguo Fei Ai Za Zhi. 2002;5(3):191–3.

    CAS  PubMed  Google Scholar 

  38. Kuo CT, Hoon DS, Takeuchi H, Turner R, Wang HJ, Morton DL, et al. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol. 2003;21(19):3566–72.

    PubMed  Google Scholar 

  39. Yanagita S, Natsugoe S, Uenosono Y, Arigami T, Funasako Y, Hirata M, et al. The utility of rapid diagnosis of lymph node metastasis in gastric cancer using a multiplex real-time reverse transcription polymerase chain reaction assay. Oncology. 2009;77(3–4):205–11.

    CAS  PubMed  Google Scholar 

  40. Nakamura T, Ide H, Eguchi R, Hayashi K, Ota M, Takasaki K. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma. J Surg Oncol. 2002;79(4):224–9.

    PubMed  Google Scholar 

  41. Zingg U, Montani M, Busch M, Metzger U, Went P, Oertli D. Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer. Eur J Surg Oncol. 2009;35(6):593–9.

    CAS  PubMed  Google Scholar 

  42. Cai J, Ikeguchi M, Maeta M, Kaibara N. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer. Surgery. 2000;127(1):32–9.

    CAS  PubMed  Google Scholar 

  43. Maehara Y, Oshiro T, Endo K, Baba H, Oda S, Ichiyoshi Y, et al. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery. 1996;119(4):397–402.

    CAS  PubMed  Google Scholar 

  44. Harrison LE, Choe JK, Goldstein M, Meridian A, Kim SH, Clarke K. Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. J Surg Oncol. 2000;73(3):153–7.

    CAS  PubMed  Google Scholar 

  45. Nakajo A, Natsugoe S, Ishigami S, Matsumoto M, Nakashima S, Hokita S, et al. Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer. Ann Surg Oncol. 2001;8(2):158–62.

    CAS  PubMed  Google Scholar 

  46. Schoenfeld A, Luqmani Y, Smith D, O’Reilly S, Shousha S, Sinnett HD, et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res. 1994;54(11):2986–90.

    CAS  PubMed  Google Scholar 

  47. Gu CD, Osaki T, Oyama T, Inoue M, Kodate M, Dobashi K, et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and survival. Ann Surg. 2002;235(1):133–9.

    PubMed  PubMed Central  Google Scholar 

  48. Niedergethmann M, Rexin M, Hildenbrand R, Knob S, Sturm JW, Richter A, et al. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma. Am J Surg Pathol. 2002;26(12):1578–87.

    PubMed  Google Scholar 

  49. Sasaki E, Nagino M, Ebata T, Oda K, Arai T, Nishio H, et al. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg. 2006;244(1):99–105.

    PubMed  PubMed Central  Google Scholar 

  50. Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer. 1999;86(12):2668–73.

    CAS  PubMed  Google Scholar 

  51. Yanagita S, Natsugoe S, Uenosono Y, Kozono T, Ehi K, Arigami T, et al. Sentinel node micrometastases have high proliferative potential in gastric cancer. J Surg Res. 2008;145(2):238–43.

    CAS  PubMed  Google Scholar 

  52. Qubain SW, Natsugoe S, Matsumoto M, Nakashima S, Baba M, Takao S, et al. Micrometastases in the cervical lymph nodes in esophageal squamous cell carcinoma. Dis Esophagus. 2001;14(2):143–8.

    CAS  PubMed  Google Scholar 

  53. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392–9.

    CAS  PubMed  Google Scholar 

  54. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391–8. discussion 8-401

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Uenosono Y, Natsugoe S, Ehi K, Arigami T, Hokita S, Aikou T. Detection of sentinel nodes and micrometastases using radioisotope navigation and immunohistochemistry in patients with gastric cancer. Br J Surg. 2005;92(7):886–9.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

    Itaru Omoto, Yasuto Uchikado, Ken Sasaki, Takaaki Arigami & Shoji Natsugoe

Authors
  1. Itaru Omoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasuto Uchikado
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ken Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takaaki Arigami
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shoji Natsugoe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Itaru Omoto .

Editor information

Editors and Affiliations

  1. Department of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima, Japan

    Shoji Natsugoe

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Omoto, I., Uchikado, Y., Sasaki, K., Arigami, T., Natsugoe, S. (2019). Clinical Aspect: Esophageal Cancer. In: Natsugoe, S. (eds) Lymph Node Metastasis in Gastrointestinal Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-10-4699-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4699-5_9

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4698-8

  • Online ISBN: 978-981-10-4699-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation